Home/Filings/4/0001104659-25-000895
4//SEC Filing

Lebovits Chaim 4

Accession 0001104659-25-000895

CIK 0001137883other

Filed

Jan 2, 7:00 PM ET

Accepted

Jan 3, 5:36 PM ET

Size

6.5 KB

Accession

0001104659-25-000895

Insider Transaction Report

Form 4
Period: 2025-01-01
Lebovits Chaim
President & CEO
Transactions
  • Award

    Common Stock

    2025-01-01+120,000200,960 total
Holdings
  • Common Stock

    (indirect: See footnote)
    133,389
Footnotes (2)
  • [F1]Represents shares of restricted stock awarded under the Issuer's 2014 Global Share Option Plan. The shares of restricted stock shall vest as to (i) 50% of the award on the six-month anniversary of the date of grant and (ii) the remaining 50% of the award shall vest on the eighteenth-month anniversary of the date of grant, provided that the Reporting Person remains employed by the Issuer through each applicable vesting date.
  • [F2]Includes (i) 128,919 shares of Common Stock owned by ACCBT Corp. and (ii) 4,470 shares of Common Stock owned by ACC International Holdings Ltd. Reporting Person may be deemed the beneficial owner of these shares.

Issuer

BRAINSTORM CELL THERAPEUTICS INC.

CIK 0001137883

Entity typeother

Related Parties

1
  • filerCIK 0001406302

Filing Metadata

Form type
4
Filed
Jan 2, 7:00 PM ET
Accepted
Jan 3, 5:36 PM ET
Size
6.5 KB